We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
Cap. Flow
+$12.2M
Cap. Flow %
43.59%
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47

Top Buys

Rank Stock Value
1
INSY
Insys Therapeutics, Inc.
INSY
+$637K
2
LYV icon
Live Nation Entertainment
LYV
+$625K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$462K
4
WAL icon
Western Alliance Bancorporation
WAL
+$461K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$460K

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$519K
2
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
+$510K
3
ESPR
Esperion Therapeutics
ESPR
+$443K
4
MUSA icon
Murphy USA
MUSA
+$440K
5
DGI
DigitalGlobe Inc.
DGI
+$374K

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Consumer Discretionary 13.09%
3 Healthcare 12.68%
4 Industrials 11.61%
5 Financials 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPXC icon
126
SPX Corp
SPXC
$9.39B
– –
-21,571
Closed -$201K
VIAV icon
127
Viavi Solutions
VIAV
$7.95B
– –
-17,082
Closed -$104K
VLO icon
128
Valero Energy
VLO
$89.5B
– –
-3,155
Closed -$223K
VSH icon
129
Vishay Intertechnology
VSH
$4.6B
– –
-15,498
Closed -$187K
DOOR
130
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
– –
-4,076
Closed -$250K
ICPT
131
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-1,495
Closed -$223K
MNTA
132
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-17,702
Closed -$263K
DNR
133
DELISTED
Denbury Resources, Inc.
DNR
– –
-47,133
Closed -$95K
S
134
DELISTED
Sprint Corporation
S
– –
-21,439
Closed -$78K
MDR
135
DELISTED
McDermott International
MDR
– –
-7,100
Closed -$71K
ALDR
136
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-9,360
Closed -$309K
SVU
137
DELISTED
SUPERVALU Inc.
SVU
– –
-2,274
Closed -$108K
ANDV
138
DELISTED
Andeavor
ANDV
– –
-2,238
Closed -$236K
DYN
139
DELISTED
Dynegy, Inc.
DYN
– –
-22,797
Closed -$305K
MACK
140
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-2,698
Closed -$168K
CEB
141
DELISTED
CEB Inc.
CEB
– –
-5,325
Closed -$327K
IOC
142
DELISTED
Interoil Corporation
IOC
– –
-8,341
Closed -$262K
WPG
143
DELISTED
Washington Prime Group Inc.
WPG
– –
-1,439
Closed -$137K
CKH
144
DELISTED
Seacor Holdings Inc.
CKH
– –
-6,277
Closed -$319K
TRCO
145
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
– –
-15,073
Closed -$510K
CYS
146
DELISTED
CYS Investments Inc.
CYS
– –
-10,237
Closed -$73K
DGI
147
DELISTED
DigitalGlobe Inc.
DGI
– –
-23,914
Closed -$374K
LXK
148
DELISTED
Lexmark Intl Inc
LXK
– –
-7,735
Closed -$251K
SCTY
149
DELISTED
SolarCity Corporation
SCTY
– –
-4,430
Closed -$226K
DNY
150
DELISTED
DONNELLEY R R & SONS CO
DNY
– –
-24,666
Closed -$363K
2 3 4 5
6

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2016 Portfolio in Review

As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.

  • Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
  • Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
  • Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
  • Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
  • Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
  • Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
  • Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.

Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.